Mobile Intervention for Simultaneous Alcohol and Marijuana Use in Young Adults

NARecruitingINTERVENTIONAL
Enrollment

136

Participants

Timeline

Start Date

April 1, 2024

Primary Completion Date

May 1, 2026

Study Completion Date

May 1, 2026

Conditions
Alcohol DrinkingCannabis Use
Interventions
BEHAVIORAL

Condition 1: Craving daily+PBS daily

Participants in this condition will complete ecological momentary assessment (EMA) for six weeks. Following the initial two weeks of EMA, participants in this condition will complete an introduction module including psychoeducation, personalized feedback, and goal setting. Participants will then receive craving reduction and protective behavioral strategy (PBS) messages, each delivered once daily, until the end of the six-week period.

BEHAVIORAL

Condition 2: Craving daily+PBS trigger

Participants in this condition will complete EMA for six weeks. Following the initial two weeks of EMA, participants in this condition will complete an introduction module including psychoeducation, personalized feedback, and goal setting. Participants will then receive craving reduction messages delivered once daily and PBS trigger messages that will be based on responses to signal-contingent EMA questions.

BEHAVIORAL

Condition 3: Craving trigger+PBS daily

Participants in this condition will complete EMA for six weeks. Following the initial two weeks of EMA, participants in this condition will complete an introduction module including psychoeducation, personalized feedback, and goal setting. Participants will then receive craving reduction messages that will be delivered based on responses to signal-contingent EMA questions and PBS delivered once daily.

BEHAVIORAL

Condition 4: Craving trigger+PBS trigger

Participants in this condition will complete EMA for six weeks. Following the initial two weeks of EMA, participants in this condition will complete an introduction module including psychoeducation, personalized feedback, and goal setting. Participants will then receive craving reduction and PBS messages delivered based on responses to signal-contingent EMA questions.

BEHAVIORAL

Condition 5: PBS daily+ PBS trigger

Participants in this condition will complete EMA for six weeks. Following the initial two weeks of EMA, participants in this condition will complete an introduction module including psychoeducation, personalized feedback, and goal setting. Participants will then receive PBS messages delivered once daily and PBS trigger messages that will be based on responses to signal-contingent EMA questions.

BEHAVIORAL

Condition 6: Craving daily+Craving trigger

Participants in this condition will complete EMA for six weeks. Following the initial two weeks of EMA, participants in this condition will complete an introduction module including psychoeducation, personalized feedback, and goal setting. Participants will then receive craving reduction messages delivered once daily and craving reduction trigger messages that will be based on responses to signal-contingent EMA questions.

BEHAVIORAL

Condition 7: Craving daily+Craving trigger+PBS daily+PBS trigger

Participants in this condition will complete EMA for six weeks. Following the initial two weeks of EMA, participants in this condition will complete an introduction module including psychoeducation, personalized feedback, and goal setting. Participants will then receive craving reduction and PBS messages delivered once daily and non-repetitive craving reduction and PBS trigger messages that will be based on responses to signal-contingent EMA questions.

BEHAVIORAL

Condition 8: No daily or trigger craving or PBS

Participants in this condition will complete EMA for six weeks. Following the initial two weeks of EMA, participants in this condition will complete an introduction module including psychoeducation, personalized feedback, and goal setting. Participants will not receive any further intervention strategies.

Trial Locations (1)

96815

RECRUITING

Kaiser Permanente Hawaii, Center for Integrated Health Care Research, Honolulu

All Listed Sponsors
collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

Kaiser Permanente

OTHER